Skip to content
DataLookout
Menu

LaserEnNCT04979156

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Notable Primary and study completion dates pushed to Dec 31, 2024v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2021 to Nov 4, 2021
    • Study sites: 0 to 1
    v3
  4. Minor Study description shortened, about 225 wordsv2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

To determine the ability to obtain identifiable pathologic characteristics of bladder tumor specimens by use the SOLTIVE™ laser during en bloc resection.
Timeframe: 6 months

Secondary (3)

To evaluate the overall recurrence rate as well as the recurrence rate at the prior resection site after SOLTIVE™ en bloc resection of bladder tumors.
To evaluate patient symptoms before and after en bloc tumor resection
• To evaluate short-term complications within 3 months after SOLTIVE™ en bloc resection of bladder tumors.

Arms and interventions

SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

Procedures: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

Sites

1 site in 1 country

  • University of Kansas Medical CenterKansas City, Kansas, United States